Alveolar macrophages and eicosanoids but not neutrophils, mediate bronchoconstriction induced by FMLP in the guinea‐pig
Open Access
- 1 September 1989
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 98 (1), 61-70
- https://doi.org/10.1111/j.1476-5381.1989.tb16863.x
Abstract
1 N-formyl-methionyl-leucyl-phenylalanine (FMLP), when administered by aerosol to guinea-pigs, induced a dose-dependent bronchoconstriction (BC) with no overt effect on platelet and leukocyte blood counts. Repeated administration of FMLP by aerosol was followed by desensitization. 2 Electron microscopy studies showed that administration of FMLP by aerosol is accompanied by alveolar macrophage activation, accumulation and aggregation in the alveolar lumens. Non-degranulated eosinophils were observed in the lungs and a few platelet micro-aggregates in the pulmonary microvasculature. 3 No significant accumulation of 131I-labelled albumin, 111In-labelled neutrophils or 111In-labelled platelets was detected in the lungs after the administration of FMLP by aerosol, whereas the intravenous administration was accompanied by an increase of extravascular albumin and significant neutrophil sequestration in the lungs. 4 Aspirin administered intravenously or by aerosol reduced significantly the BC induced by an aerosol of FMLP. By contrast, intravenous indomethacin reduced only BC induced by the sub-maximal dose of FMLP as an aerosol whereas, when administered by inhalation, it inhibited BC induced by FMLP administered either intravenously or by aerosol at all the concentrations tested. 5 FMLP induced a dose-dependent contraction of the guinea-pig trachea, which was not inhibited by indomethacin. 6 The dual cyclo-oxygenase/lipoxygenase inhibitor compound BW755C suppressed the BC induced by an aerosol of FMLP at all the concentrations used, whereas the histamine H1-antagonist mepyramine was inactive. 7 Leukocyte depletion with vinblastine failed to reduce BC induced by intravenous or an aerosol of FMLP. 8 Our studies indicate that: (a) FMLP administered by aerosol induces dose-dependent BC followed by desensitization, indicating that local mechanisms account for BC; (b) BC induced by i.v. FMLP, but not by its inhalation, is accompanied by albumin extravasation and neutrophil sequestration in the lungs; (c) BC by either i.v. or an aerosol of FMLP is not due to neutrophil activation; (d) inhalation of FMLP induces BC accompanied by accumulation of activated alveolar macrophages, non-degranulated eosinophils and a few platelet microaggregates in the lung; (e) both cyclo-oxygenase and lipoxygenase metabolites are involved in the BC induced by an aerosol of FMLP.This publication has 31 references indexed in Scilit:
- Skin eosinophilia in atopic patientsJournal of Allergy and Clinical Immunology, 1988
- Involvement of PAF-Acether in Anaphylactic Bronchoconstriction Induced in Guinea Pigs by Aerosolized AntigenInternational Archives of Allergy and Immunology, 1988
- Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU 41821 aerosolAntimicrobial Agents and Chemotherapy, 1987
- Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.JCI Insight, 1987
- Secretory products of macrophages.JCI Insight, 1987
- Failure of a combined anti-histamine and anti-leukotriene treatment to suppress passive anaphylaxis in the guinea-pigInternational Journal of Immunopharmacology, 1986
- Effects of Compound 48/80 and Formyl-Methionyl-Leucyl-Phenylalanine on Isolated Guinea Pig AirwaysInternational Archives of Allergy and Immunology, 1984
- Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotoninEuropean Journal of Pharmacology, 1982
- Control of vascular permeability by polymorphonuclear leukocytes in inflammationNature, 1981